Dudley John Pennell

Dudley John Pennell

Auto-generated profile, based on publicly available information

Dudley John Pennell

National Heart and Lung Institute, Imperial College London

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2002 in Circulation
Verified
Journal Article
Closed access
AIAmerican Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging:
American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging:
MCManuel D. Cerqueira
Manuel D. Cerqueira
NWNeil J. Weissman
Neil J. Weissman
VDVasken Dilsizian
Vasken Dilsizian
AJAlice K. K. Jacobs
Alice K. K. Jacobs
MVMario S. Verani
Mario S. Verani

1 December 2001 in European Heart Journal
Verified
Journal Article
Open access
PDF file
LAL.J. Anderson
L.J. Anderson
SHS. Holden
S. Holden
BDB. Davis
B. Davis
EPE. Prescott
E. Prescott
CCC.C. Charrier
C.C. Charrier
DPD.J. Pennell
D.J. Pennell
Aims To develop and validate a non-invasive method for measuring myocardial iron in order to allow diagnosis and treatment before overt cardiomyopath

16 February 2012 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
DHDaniel S. Herman
Daniel S. Herman
LLLien Lam
Lien Lam
MTMatthew R.G. Taylor
Matthew R.G. Taylor
LWLibin Wang
Libin Wang
PTPolakit Teekakirikul
Polakit Teekakirikul
CSChristine Seidman
Christine Seidman
Dilated cardiomyopathy and hypertrophic cardiomyopathy arise from mutations in many genes. TTN, the gene encoding the sarcomere protein titin, has been insufficiently analyzed for cardiomyopathy mutations because of its enormous size. We analyzed TTN in 312 subjects with dilated cardiomyopathy, 231 subjects with hypertrophic cardiomyopathy, and 249 controls by using next-generation or dideoxy sequencing. We evaluated deleterious variants for cosegregation in families and assessed clinical characteristics. We identified 72 unique mutations (25 nonsense, 23 frameshift, 23 splicing, and 1 large tandem insertion) that altered full-length titin. Among subjects studied by means of next-generation sequencing, the frequency of TTN mutations was significantly higher among subjects with dilated cardiomyopathy (54 of 203 [27%]) than among subjects with hypertrophic cardiomyopathy (3 of 231 [1%], P=3×10−16) or controls (7 of 249 [3%], P=9×10−14). TTN mutations cosegregated with dilated cardiomyopathy in families (combined lod score, 11.1) with high (>95%) observed penetrance after the age of 40 years. Mutations associated with dilated cardiomyopathy were overrepresented in the titin A-band but were absent from the Z-disk and M-band regions of titin (P≤0.01 for all comparisons). Overall, the rates of cardiac outcomes were similar in subjects with and those without TTN mutations, but adverse events occurred earlier in male mutation carriers than in female carriers (P=4×10−5). TTN truncating mutations are a common cause of dilated cardiomyopathy, occurring in approximately 25% of familial cases of idiopathic dilated cardiomyopathy and in 18% of sporadic cases. Incorporation of sequencing approaches that detect TTN truncations into genetic testing for dilated cardiomyopathy should substantially increase test sensitivity, thereby allowing earlier diagnosis and therapeutic intervention for many patients with dilated cardiomyopathy. Defining the functional effects of TTN truncating mutations should improve our understanding of the pathophysiology of dilated cardiomyopathy. (Funded by the Howard Hughes Medical Institute and others.)

1 July 2002 in The American Journal of Cardiology
Verified
Journal Article
Closed access
FGFrank Grothues
Frank Grothues
GSGillian C Smith
Gillian C Smith
JMJames C.C Moon
James C.C Moon
NBNicholas G Bellenger
Nicholas G Bellenger
PCPeter Collins
Peter Collins
DPDudley J Pennell
Dudley J Pennell

6 March 2013 in JAMA
Verified
Journal Article
Open access
PDF file
AGAnkur Gulati
Ankur Gulati
AJAndrew Jabbour
Andrew Jabbour
TITevfik F. Ismail
Tevfik F. Ismail
KGKaushik Guha
Kaushik Guha
JKJahanzaib Khwaja
Jahanzaib Khwaja
SPSanjay K. Prasad
Sanjay K. Prasad
Nonischemic dilated cardiomyopathy is a common heart muscle disease with a prevalence of at least 1 in 2500 adults.1 It is characterized by left ventricular cavity enlargement and impaired contractility in the absence of significant coronary artery disease.1 The condition is associated with significant morbidity and mortality due to progressive heart failure (HF) and sudden cardiac death (SCD).2 Despite therapeutic advances, 5-year mortality remains as high as 20%.2 Risk stratification in dilated cardiomyopathy therefore constitutes a crucial part of patient management with implications for surveillance, treatment, and outcome. Currently, risk stratification is heavily dependent on the assessment of left ventricular ejection fraction (LVEF), as exemplified by its use as the key determinant of device implantation.3 Although LVEF is an important prognostic factor in dilated cardiomyopathy,4,5 effective risk stratification remains challenging, particularly with respect to SCD.6,7 Most patients who experience SCD do not have severely reduced LVEF, and many patients with significant impairment of LVEF may still be at low risk for SCD.7,8 Identification of better independent prognostic factors is necessary to enable clinicians to more accurately stratify risk in patients with dilated cardiomyopathy and tailor management accordingly.

1 January 2020 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
JSJeanette Schulz-Menger
Jeanette Schulz-Menger
DBDavid A. Bluemke
David A. Bluemke
JBJens Bremerich
Jens Bremerich
SFScott D. Flamm
Scott D. Flamm
MFMark A. Fogel
Mark A. Fogel
ENEike Nagel
Eike Nagel
With mounting data on its accuracy and prognostic value, cardiovascular magnetic resonance (CMR) is becoming an increasingly important diagnostic tool with growing utility in clinical routine. Given its versatility and wide range of quantitative parameters, however, agreement on specific standards for the interpretation and post-processing of CMR studies is required to ensure consistent quality and reproducibility of CMR reports. This document addresses this need by providing consensus recommendations developed by the Task Force for Post-Processing of the Society for Cardiovascular Magnetic Resonance (SCMR). The aim of the Task Force is to recommend requirements and standards for image interpretation and post-processing enabling qualitative and quantitative evaluation of CMR images. Furthermore, pitfalls of CMR image analysis are discussed where appropriate. It is an update of the original recommendations published 2013.